Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Monica Bertagnolli, MD
Alliance Foundation Trials, LLC.
Principal Investigator - Thomas Hensing, MD
Endeavor Health
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsd Moores Cancer Center
La Jolla, California, United States
- the University of Chicago Medical Center
Chicago, Illinois, United States
- Northshore University Healthsystem
Evanston, Illinois, United States
- Medical Oncology & Hematology Associates
Des Moines, Iowa, United States
- Emmc Cancer Care
Brewer, Maine, United States
- Metro Mn Community Oncology Research Consortium
Minneapolis, Minnesota, United States
- Nh Oncology (concord)
Concord, New Hampshire, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- the Ohio State University
Columbus, Ohio, United States
- University of Oklahoma Health Sciences Center Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2016
- Primary completion
- 4 Jan 2019
- Completion
- 4 Jul 2020
- Last update posted
- 28 Dec 2022
- Registered enrollment
- 91
- Registry id
- NCT02591615
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.